Search research articles
Contact Us
Filters
Showing results (111-120 of 391) with videos related to
Page
of 40
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
August 15, 2024
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the <i>AJRCCM</i> Special Issue on ILD (Part 2)
Anna J Podolanczuk, Toby M Maher, Wonder P Drake, et al.
ERJ Open Research
|
February 25, 2026
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
Toby M Maher, R Gisli Jenkins, Francesco Bonella, et al.
Respirology (Carlton, Vic.)
|
August 30, 2023
Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis
Toby M Maher, Susanne Stowasser, Florian Voss, et al.
Thorax
|
September 28, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Martin Kolb, Luca Richeldi, Jürgen Behr, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2013
Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease
Arnab Datta, Robert Alexander, Michal G Sulikowski, et al.
BMC Pulmonary Medicine
|
September 17, 2017
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries
Toby M Maher, Maria Molina-Molina, Anne-Marie Russell, et al.
Thorax
|
February 1, 2014
Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register
Rebecca H Mason, Noeleen M Foley, Howard M Branley, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 1, 2024
Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis
Zhe Wu, David J F Smith, Leda Yazbeck, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 1, 2024
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special Issue
Toby M Maher, Anna J Podolanczuk, Wonder P Drake, et al.
ERJ Open Research
|
July 22, 2025
Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications
Tejaswini Kulkarni, Joel Santiaguel, Raminder Aul, et al.
Page
of 40
Search research articles
Search
Showing results (111-120 of 391) with videos related to
Sort By:
Page
of 40
American Journal of Respiratory and Critical Care Medicine
|
August 15, 2024
Pioneering Research Driving Progress toward a Cure for Interstitial Lung Disease (ILD): Introduction to the <i>AJRCCM</i> Special Issue on ILD (Part 2)
Anna J Podolanczuk, Toby M Maher, Wonder P Drake, et al.
ERJ Open Research
|
February 25, 2026
Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
Toby M Maher, R Gisli Jenkins, Francesco Bonella, et al.
Respirology (Carlton, Vic.)
|
August 30, 2023
Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis
Toby M Maher, Susanne Stowasser, Florian Voss, et al.
Thorax
|
September 28, 2016
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Martin Kolb, Luca Richeldi, Jürgen Behr, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 2, 2013
Evidence for a functional thymic stromal lymphopoietin signaling axis in fibrotic lung disease
Arnab Datta, Robert Alexander, Michal G Sulikowski, et al.
BMC Pulmonary Medicine
|
September 17, 2017
Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries
Toby M Maher, Maria Molina-Molina, Anne-Marie Russell, et al.
Thorax
|
February 1, 2014
Pulmonary Langerhans cell histiocytosis (PLCH): a new UK register
Rebecca H Mason, Noeleen M Foley, Howard M Branley, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 1, 2024
Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis
Zhe Wu, David J F Smith, Leda Yazbeck, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 1, 2024
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special Issue
Toby M Maher, Anna J Podolanczuk, Wonder P Drake, et al.
ERJ Open Research
|
July 22, 2025
Deupirfenidone (LYT-100) in post-acute sequelae of SARS-CoV-2 with respiratory complications
Tejaswini Kulkarni, Joel Santiaguel, Raminder Aul, et al.
Page
of 40